Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023 at 06:00 AM EDT
Leqembi is the first Alzheimer's antibody treatment to receive full FDA approval.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
